Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.

about

Molecular Signatures of the Insulin-like Growth Factor 1-mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers

P2860

Q58776408-3D4E1865-6110-4137-9D45-BA722F70D1D7

P2860

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.

Item

http://www.wikidata.org/entity/Q49887886

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.

@en

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.

@nl

type

Item

label

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.

@en

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.

@nl

prefLabel

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.

@en

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.

@nl

P1476

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.

@en

P2093

Haim Werner

http://www.w3.org/2001/XMLSchema#string

Ilan Bruchim

http://www.w3.org/2001/XMLSchema#string

Shilhav Meisel-Sharon

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation

A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1

The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3

Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3

The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor

EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts

The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains

Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

P2888

s12943-018-0807-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/S12943-018-0807-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101066807

http://www.w3.org/2001/XMLSchema#string

P698

29455671

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

P932

5817802

http://www.w3.org/2001/XMLSchema#string

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.

about

P2860

P2860

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932